Clinical potential of Spirulina as a source of phycocyanobilin.
about
Suppression of NADPH Oxidase Activity May Slow the Expansion of Osteolytic Bone MetastasesAsymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Algae as nutritional and functional food sources: revisiting our understandingThe molecular biology and pathophysiology of vascular calcification.Phycocyanobilin accelerates liver regeneration and reduces mortality rate in carbon tetrachloride-induced liver injury mice.Antioxidant Effect of Spirulina (Arthrospira) maxima on Chronic Inflammation Induced by Freund's Complete Adjuvant in RatsStabilization of Human Serum Albumin by the Binding of Phycocyanobilin, a Bioactive Chromophore of Blue-Green Alga Spirulina: Molecular Dynamics and Experimental Study.Redox control of renal function and hypertension.NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for Prevention.Systems biology and metabolic engineering of Arthrospira cell factories.Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Recent developments in production and biotechnological applications of C-phycocyanin.Practical strategies for modulating foam cell formation and behavior.Biotechnological exploitation of microalgae.The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: an overview.Induction of apoptosis in human colon carcinoma COLO 205 cells by the recombinant α subunit of C-phycocyanin.Marine blue green algae: Microorganism of bioactive potential.Supplemental N-acetylcysteine and other measures that boost intracellular glutathione can downregulate interleukin-1β signalling: a potential strategy for preventing cardiovascular events?Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.The effect of hydrolyzed Spirulina by malted barley on forced swimming test in ICR mice.C-Phycocyanin as a tumour-associated macrophage-targeted photosensitiser and a vehicle of phthalocyanine for enhanced photodynamic therapy.C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.Spirulina platensis and phycocyanobilin activate atheroprotective heme oxygenase-1: a possible implication for atherogenesis.Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.Two-stage culture method for optimized polysaccharide production in Spirulina platensisAntioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complicationsAortic Response to Strength Training and Dependent on Nitric Oxide and Antioxidants
P2860
Q26738400-A4ED8E6A-AE7C-4646-9401-CB88C491DD93Q28075206-27A5336C-24B4-4A53-91BD-99AFC042211FQ30844837-4BEF5041-3909-4E1B-B214-31E70C38C054Q34412941-46A33479-59CD-4C84-A356-83EB931B2374Q35594184-A08420A1-09BB-48B7-8FA5-E86D83155751Q35911021-FED5CCE4-CB3C-40CA-B0A6-A91FDC94A953Q36222212-E2254862-CE56-4137-BCC5-8FAD185E8AA3Q36970633-AB331858-99A1-4748-A641-33E8870A5F12Q37081593-E32CBF99-43B1-46C0-B875-F962129F7B1AQ37654851-BED4255E-765B-406F-AF0B-C62E3D81A7D9Q37728038-ADA465C4-A325-4368-98DF-FC2D291B7813Q38142180-82EDFDEE-96D5-482E-BF35-EC19368887E7Q38261037-F5D2ECAF-E3B8-4893-8C6F-B6BFE86D7982Q38591992-866D1A55-04DA-4D84-8ED2-F466DD11165AQ38853168-2DE984E2-B7E9-42E0-A0A1-A575ED1A0E7AQ39632671-A53E2248-E0AB-451E-9CDD-FE09E37ADC36Q41818823-1A384CEE-8149-4EC4-B12A-3761C81F8AB9Q42351011-7845D8CA-64CF-4FC3-A66D-C3BA514BDE1EQ42355197-C2728B3D-A4EA-4A55-8F8C-54E418268974Q46318077-C182711A-0A3D-4CD2-857A-8072715A0768Q48043619-2755F291-871F-43D9-AD6A-1BA7B21D6AC7Q49272997-372174F2-AC78-4922-9344-F17F5D4DBFCBQ50229330-2F6C3A7B-A882-4DF6-901F-84F565B37C5FQ50455684-AD0F07E1-9A74-461C-921D-3FB31E80F577Q57119355-367C4471-78B8-4D9D-B8BF-299F9CB38692Q58558363-5B96644E-9DBB-49CC-BF59-B9B90FD5D4C3Q59133621-732440AE-B71D-4086-A587-C943FE04A71D
P2860
Clinical potential of Spirulina as a source of phycocyanobilin.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Clinical potential of Spirulina as a source of phycocyanobilin.
@ast
Clinical potential of Spirulina as a source of phycocyanobilin.
@en
Clinical potential of Spirulina as a source of phycocyanobilin.
@nl
type
label
Clinical potential of Spirulina as a source of phycocyanobilin.
@ast
Clinical potential of Spirulina as a source of phycocyanobilin.
@en
Clinical potential of Spirulina as a source of phycocyanobilin.
@nl
prefLabel
Clinical potential of Spirulina as a source of phycocyanobilin.
@ast
Clinical potential of Spirulina as a source of phycocyanobilin.
@en
Clinical potential of Spirulina as a source of phycocyanobilin.
@nl
P356
P1476
Clinical potential of Spirulina as a source of phycocyanobilin.
@en
P2093
Mark F McCarty
P304
P356
10.1089/JMF.2007.621
P577
2007-12-01T00:00:00Z